Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 297 results found. Search for [ Drug patent ]

Results 1 to 21 of 297
BusinessToday.In
July 16, 2018
The Dr Reddy's stock fell up to 10.61% or 246 points to 2,071.50 level. The stock closed 9.85% or 228 points lower at 2089.15 on the BSE.


E Kumar Sharma
New Delhi, June 19, 2018
It wants to focus on India and other emerging markets, while at some stage, perhaps sometime in 2019, it may also look at a foray into the US market. It already has an office in Boston and is scouting for a partner in the US.


PTI
May 25, 2018



PTI
May 17, 2018



Joe C Mathew
New Delhi, May 4, 2018
Chinese Ambassador to India Luo Zhaohui's recent tweet on his country's decision to remove import duties on 28 medicines, including all cancer drugs, has created flutters in India.


P.B. Jayakumar
New Delhi, April 30, 2018
Drug companies are moving up the value chain, transforming into complex generic manufacturers with high end R&D facilities.


Joe C Mathew
New Delhi, April 24, 2018
The report, which studied the prosecution history of some grants and the claim language of all granted patents during 2009-2016, states that the grants were likely contravention of anti-evergreening provisions under section 3 of the Indian Patents Act.


PTI
April 3, 2018



Joe C Mathew
New Delhi, March 13, 2018
Close to 90 health activists, patient groups and individuals workingtowards the elimination of tuberculosis have called upon Prime MinisterNarendra Modi to make drug resistant TB (DR-TB) drugs affordable byensuring supply of generic drugs


PB Jayakumar
New Delhi, February 21, 2018
The competition to tap large molecule structured complex bio-similars or off-patent biotech drugs is heating up.


Joe C Mathew
New Delhi, February 13, 2018
US based drug makers lobby group Pharmaceutical Research and Manufacturers of America (PhRMA) has complained that the positive signals given by India


PTI
January 31, 2018



E. Kumar Sharma
New Delhi, January 10, 2018
By following the strategy of doing a few things well, V.C. Nannapaneni has helped Natco Pharma carve out a space for itself.


PTI
January 4, 2018



E Kumar Sharma
New Delhi, December 19, 2017
On December 7th, Mylan launched 'HepBest', which it called, \"the first drug approved in eight years for management of chronic Hepatitis B infection in India.\" 


PTI
December 19, 2017



P.B. Jayakumar
New Delhi, December 11, 2017
Margin erosion and regulatory hurdles are hitting Indian pharma companies hard in their biggest market.


E Kumar Sharma
New Delhi, November 12, 2017
Every business has the right to adopt legitimate practises to protect their own interest. Right? But a recent article argues that going beyond the patent act, which permits research and development during the life of a patent, some innovator drug companies are busy trying to block this.


Niti Kiran
New Delhi, September 16, 2017
India is seeing a slump in drug exports since the beginning of the fiscal driven by a decline in the sale of Indian drugs in the US.


Joe C Mathew
New Delhi, August 22, 2017
NGO Medicines Sans Frontiers had challenged the patent claims of Pfizer, calling it way to gain market monopoly. The MSF has argued that Indian firms can supply the same vaccine for much less.


PAGES 1 OF 15  12345